Anebulo Pharmaceuticals Names Biotechnology Industry Executive Simon Allen as CEO and Director
Cannabis Law Report
JANUARY 4, 2022
Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance abuse, has named Simon Allen as Chief Executive Officer and a member of the company’s Board of Directors, effective February 1 st , 2022. and Australia.
Let's personalize your content